Daily Derm Times: June 4, 2025

To stay up-to-date with the latest dermatology news, sign up to receive our eNewsletters.

Journal Digest: June 4, 2025

This review of the latest dermatologic studies includes insights into clinical manifestations of mpox infection, therapeutic modulation of Demodex density via isotretinoin, and more.

Denifanstat Hits All Targets in Chinese Study

Sagimet Biosciences reveals denifanstat's promising phase 3 results, offering a novel oral treatment for moderate to severe acne with significant efficacy.

Bridging the Gaps in Lichen Planus Treatment: Emerging Therapies and Clinical Realities

In part 2 of this conversation, Adam Friedman, MD, FAAD, discusses new data on lichen planus treatment trends, unmet needs, and the promise of innovative therapies.

Examining the Halfway Mark of 2025 in Dermatology

Discover the latest advancements in dermatology in our June issue, including FDA approvals, innovative treatments, and expert insights shaping patient care today.

Road to RAD: What’s Next in the AD Pipeline?

Jonathan Silverberg, MD, PhD, MPH, shared insights into the rapidly evolving therapeutic landscape for atopic dermatitis.

Time in the Market: What History Tells Us About Investing During Volatile Markets

Market pullbacks tempt investors to time the market, but history shows staying invested beats guessing the highs and lows—time > timing.